| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/24/2011 | US7947277 Wnt antagonists and their use in the diagnosis and treatment of Wnt-mediated disorders |
| 05/24/2011 | US7947276 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| 05/24/2011 | US7947275 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 05/24/2011 | US7947274 Human cytomegalovirus neutralising antibodies and use thereof |
| 05/24/2011 | US7947273 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma |
| 05/24/2011 | US7947272 Using mixture comprising inhibitors of CD4, CD25 and interleukin induction as tool in reducing immune response to tissue graft; preventing transplant rejection |
| 05/24/2011 | US7947271 Methods of decreasing tumor volume and reducing tumor burden using TNF-receptor-coupling agents |
| 05/24/2011 | US7947262 Administering fullerenes to which are attached IgE Fc or stem cell factor (SCF) peptides |
| 05/24/2011 | US7947254 Method of detecting a neuromyelitis optica specific-autoantibody by an antigenic aquaporin-4 polypeptide |
| 05/24/2011 | CA2504663C Methods of using and compositions comprising immunomudulatory compounds for the treatment and management of myeloproliferative diseases |
| 05/24/2011 | CA2420621C Microparticle compositions and methods for the manufacture thereof |
| 05/24/2011 | CA2401604C Method of treating cancer with anti-neurotrophin agents |
| 05/24/2011 | CA2360382C Use of antibodies for the vaccination against cancer |
| 05/24/2011 | CA2345277C Methods for isolation, quantification, characterization and modulation of antigen-specific t cells |
| 05/24/2011 | CA2341642C Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 05/24/2011 | CA2339487C Targeting and prolonging association of drugs to the luminal surface of the pulmonary vascular endothelial cells |
| 05/24/2011 | CA2337754C Recombinant multivalent malarial vaccine against plasmodium falciparum |
| 05/24/2011 | CA2323072C Gfr.alpha.3 and its uses |
| 05/24/2011 | CA2319310C Equine fc epsilon receptor alpha chain nucleic acid molecules, corresponding proteins and uses thereof |
| 05/24/2011 | CA2270913C Human tumor necrosis factor receptor-like 2 |
| 05/24/2011 | CA2266640C Methods for treating an ischemic disorder and improving stroke outcome |
| 05/24/2011 | CA2258017C Immunstimulating lipid formulation |
| 05/24/2011 | CA2227860C Avirulent herpetic viruses useful as tumoricidal agents and vaccines |
| 05/24/2011 | CA2211687C Vascular endothelial growth factor-b |
| 05/24/2011 | CA2184890C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 05/24/2011 | CA2133409C Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens |
| 05/19/2011 | WO2011060379A2 (poly)-glycerolphosphate-based anti-gram positive bacterial vaccine |
| 05/19/2011 | WO2011060260A2 Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors |
| 05/19/2011 | WO2011060246A2 A method of promoting dendritic spine density |
| 05/19/2011 | WO2011060233A1 Anti-tem1 antibodies and uses thereof |
| 05/19/2011 | WO2011060093A2 Compositions, methods and uses for stimulating immune responses |
| 05/19/2011 | WO2011059950A1 Actinobacillus suis antigens |
| 05/19/2011 | WO2011059755A2 Dual variable domain immunoglobulins and uses thereof |
| 05/19/2011 | WO2011059684A1 Antibody glycosylation variants |
| 05/19/2011 | WO2011059482A1 Plasmodium falciparum hla class i restricted t-cell epitopes |
| 05/19/2011 | WO2011059478A1 Th1/th2 polarizing vaccines |
| 05/19/2011 | WO2011059385A1 Immunizing composition for reducing streptococcal infections |
| 05/19/2011 | WO2011059334A1 Use of newcastle disease virus-based vector for inducing an immune response in mammals |
| 05/19/2011 | WO2011059110A1 Therapeutic agent for psoriasis or atopic dermatitis |
| 05/19/2011 | WO2011058993A1 Method for screening for novel bone resorption inhibitor |
| 05/19/2011 | WO2011058400A1 Non-dna base-containing polynucleotide compositions and their use for the modulation of immune responses |
| 05/19/2011 | WO2011058368A1 Immune system modulating composition |
| 05/19/2011 | WO2011058302A1 Bacteremia-associated antigen from staphylococcus aureus |
| 05/19/2011 | WO2011058183A1 Par-1 antagonists for use in the treatment or prevention of influenza virus type a infections |
| 05/19/2011 | WO2011058137A1 The use of an l3 and/or l5 source as a vaccine or as a diagnostic for a parasitic disease |
| 05/19/2011 | WO2011058080A1 Anti-trypanosomiasis vaccines and diagnostics |
| 05/19/2011 | WO2011058055A1 Anti-trypanosome therapeutic and diagnostic applications |
| 05/19/2011 | WO2011057788A1 Antibodies specific for claudin 6 (cldn6) |
| 05/19/2011 | WO2011057437A1 Anti-epidemic growth factor receptor antibody and encoding genes and uses thereof |
| 05/19/2011 | WO2011057436A1 Anti-epidermal growth factor receptor antibodies and uses thereof |
| 05/19/2011 | WO2011057435A1 Anti-epidermal growth factor receptor antibodies and uses thereof |
| 05/19/2011 | WO2011037859A3 Identification of antigenic peptides from multiple myeloma cells |
| 05/19/2011 | WO2011029607A8 S. aureus allergen |
| 05/19/2011 | WO2011014416A3 High yield yellow fever virus strain with increased propagation in cells |
| 05/19/2011 | WO2011007350A3 Use of nle proteins and tissue - targeted delivery system thereof for the treatment of imune-related disorders |
| 05/19/2011 | WO2011002852A3 Pro-drug complexes and related methods of use |
| 05/19/2011 | WO2011002836A3 Attenuated enterohemorrhagic e.coli-based vaccine vector and methods relating thereto |
| 05/19/2011 | WO2010144602A3 Antigen-norovirus p-domain monomers and dimers, antigen-norovirus p-particle molecules, and methods for their making and use |
| 05/19/2011 | WO2010144140A3 Egfr and par2 regulation of intestinal permeability |
| 05/19/2011 | WO2010120874A3 Chimeric therapeutics, compositions, and methods for using same |
| 05/19/2011 | WO2009046407A3 B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS |
| 05/19/2011 | US20110118446 Methods and compositions for antibody production |
| 05/19/2011 | US20110118445 Inhibitor protein of the wnt signal pathway |
| 05/19/2011 | US20110118194 Therapeutic Use of LPI, a Staphylococcal Lectin Pathway Inhibitor in Inflammatory Diseases |
| 05/19/2011 | US20110118185 Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization |
| 05/19/2011 | US20110117640 Tumor antigens bfa4 and bcy1 for prevention and / or treatment of cancer |
| 05/19/2011 | US20110117204 Immunologically active compositions |
| 05/19/2011 | US20110117202 Up and down conversion systems for production of emitted light from various energy sources including radio frequency, microwave energy and magnetic induction sources for upconversion |
| 05/19/2011 | US20110117191 Mixture of substances on the basis of a mixture of essential oils and use |
| 05/19/2011 | US20110117184 Compositions for mucosal delivery of agents |
| 05/19/2011 | US20110117170 Controlled Release of Growth Factors and Signaling Molecules for Promoting Angiogenesis |
| 05/19/2011 | US20110117143 TREATMENT OF CELIAC DISEASE WITH IgA |
| 05/19/2011 | US20110117137 Tapasin augmentation for enhanced immune response |
| 05/19/2011 | US20110117135 Method of Forming Dendritic Cells from Embryonic Stem Cells |
| 05/19/2011 | US20110117134 Gene library of Brucella suis surface antigens |
| 05/19/2011 | US20110117133 Novel Recombinant BCG Tuberculosis Vaccine Designed to Elicit Immune Responses to Mycobacterium Tuberculosis in all Physiological Stages of Infection and Disease |
| 05/19/2011 | US20110117132 Mutated salmonella typhi strain and use thereof in a vaccine |
| 05/19/2011 | US20110117131 Production of OspA for Lyme Disease Control |
| 05/19/2011 | US20110117130 Method of diagnosing and treating Ehrlichia |
| 05/19/2011 | US20110117129 Vaccine Against Highly Pathogenic Porcine Reproductive and Respiratory Syndrome (HP PRRS) |
| 05/19/2011 | US20110117128 Compositions that Include Hemagglutinin, Methods of Making and Methods of Use Thereof |
| 05/19/2011 | US20110117127 Analysis of dna by means of capillary electrophoresis |
| 05/19/2011 | US20110117126 Attenuated pestivirus |
| 05/19/2011 | US20110117125 Compositions and methods for the delivery of nucleic acids |
| 05/19/2011 | US20110117124 Enhancement of transgene expression from viral-based vaccine vectors by expression of suppressors of the type i interferon response |
| 05/19/2011 | US20110117123 Multivalent Vaccine Composition With Mixed Carrier |
| 05/19/2011 | US20110117120 Plasmodium falciparum HLA class I restricted T-cell epitopes |
| 05/19/2011 | US20110117119 Novel compositions and methods |
| 05/19/2011 | US20110117118 Molecules, compositions, methods and kits for applications associated with flaviviruses |
| 05/19/2011 | US20110117117 Novel immunogenic epitopes for immunotherapy |
| 05/19/2011 | US20110117116 Nucleic acids encoding a house dust mite allergen, der p iii, and uses therefor |
| 05/19/2011 | US20110117115 Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders |
| 05/19/2011 | US20110117114 Neovascular-Targeted Immunoconjugates |
| 05/19/2011 | US20110117113 Immunoglobulin single variable domain directed against human cxcr4 and other cell associated proteins and methods to generate them |
| 05/19/2011 | US20110117112 Sodium channel protein type iii alpha-subunit splice variant |
| 05/19/2011 | US20110117111 Microrna-based diagnostic testing and therapies for inflammatory bowel disease and related diseases |
| 05/19/2011 | US20110117110 Anti-egfr antibodies and their uses |
| 05/19/2011 | US20110117109 Cytomegalovirus disintegrin-like peptides |
| 05/19/2011 | US20110117108 Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
| 05/19/2011 | US20110117107 Compositions and methods for diagnosis, prognosis and management of malaria |